Oddway International

Trioday is a brand name for a medication that contains the active ingredient tenofovir disoproxil fumarate, which is used primarily in the treatment and prevention of HIV (human immunodeficiency virus) and as part of pre-exposure prophylaxis (PrEP) for individuals at high risk for HIV infection. The typical dosages of tenofovir disoproxil fumarate can vary based on the treatment context and specific patient needs.

Tenofovir Disoproxil Fumarate (TDF) is an antiviral medication commonly used for the treatment of HIV infection and chronic hepatitis B. The 300 mg dosage is a standard dose for adults in the management of these conditions.

Tenofovir works by inhibiting reverse transcriptase, an enzyme crucial for the virus's replication process. It is often part of combination therapy, meaning it is used alongside other antiretroviral medications to enhance overall efficacy and prevent the development of drug resistance.

Viraday is an antiviral medication used primarily in the treatment of HIV/AIDS. It is a combination of two antiretroviral drugs: Lamivudine and Tenofovir. This combination works by inhibiting the reverse transcriptase enzyme, which plays a crucial role in the replication of the HIV virus.

Tenofovir Disoproxil Fumarate (TDF) is an antiretroviral medication used primarily in the treatment of HIV and in the prevention of HIV infection (pre-exposure prophylaxis, or PrEP). It belongs to a class of drugs known as nucleotide reverse transcriptase inhibitors (NRTIs).

Tenofovir alafenamide (TAF) is an antiviral medication used primarily in the treatment of HIV (human immunodeficiency virus) and hepatitis B virus (HBV) infections. It is a prodrug of tenofovir and is part of the class of medications known as nucleoside reverse transcriptase inhibitors (NRTIs).